Format

Send to

Choose Destination
See comment in PubMed Commons below
J Matern Fetal Neonatal Med. 2012 Oct;25(Suppl 5):93-6. doi: 10.3109/14767058.2012.716985.

A consistent approach to platelet transfusion in the NICU.

Author information

1
Division of Neonatology, Neonatal Intensive Care Unit, Di Venere Hospital, Bari, Italy. delveccant@libero.it

Abstract

Platelet transfusions are the principal means of treating thrombocytopenia in neonatal intensive care units (NICUs), and are generally used as treatment of thrombocytopenic neonates who have active bleeding and as prophylactic administration in thrombocytopenic neonates who do not have hemorrhage but appear to be at high risk for bleeding. In this article, we summarize the rationale, benefits and risks of platelet transfusions in neonates. We review the importance of choosing the best product available for platelet transfusion, and we emphasize the importance of adopting and adhering to transfusion guidelines.

PMID:
23025779
DOI:
10.3109/14767058.2012.716985
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis
    Loading ...
    Support Center